Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Corsaro

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Endocrinology|March 11, 2020
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem CellsRoberto Würth, Stefano Thellung, Alessandro Corsaro, et al.
International Journal of Molecular Sciences|February 23, 2019
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein ToxicityStefano Thellung, Alessandro Corsaro, Mario Nizzari, et al.
International Journal of Molecular Sciences|September 4, 2012
Role of prion protein aggregation in neurotoxicityAlessandro Corsaro, Stefano Thellung, Valentina Villa, et al.
Molecular Endocrinology (Baltimore, Md.)|September 25, 2004
Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathwaysSara Arena, Alessandra Pattarozzi, Alessandro Corsaro, et al.
Neuro-Degenerative Diseases|June 29, 2007
Amyloid precursor protein and presenilin involvement in cell signalingValentina Venezia, Mario Nizzari, Pia Carlo, et al.
Frontiers in Neuroscience|September 23, 2022
Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targetsStefano Thellung, Alessandro Corsaro, Irene Dellacasagrande, et al.
Omics : a Journal of Integrative Biology|February 11, 2012
Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicityAlessandro Corsaro, Stefano Thellung, Valentina Villa, et al.
Expert Opinion on Therapeutic Targets|November 25, 2024
Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targetsAlessandro Corsaro, Beatrice Tremonti, Adriana Bajetto, et al.
Cancer Cell International|December 24, 2024
The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human glioblastoma cellsAlessandro Corsaro, Irene Dellacasagrande, Michele Tomanelli, et al.
Clinical Endocrinology|October 2, 2002
In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomasMassimo Giusti, Liliana Bocca, Tullio Florio, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Endocrinology|March 11, 2020
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem CellsRoberto Würth, Stefano Thellung, Alessandro Corsaro, et al.
International Journal of Molecular Sciences|February 23, 2019
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein ToxicityStefano Thellung, Alessandro Corsaro, Mario Nizzari, et al.
International Journal of Molecular Sciences|September 4, 2012
Role of prion protein aggregation in neurotoxicityAlessandro Corsaro, Stefano Thellung, Valentina Villa, et al.
Molecular Endocrinology (Baltimore, Md.)|September 25, 2004
Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathwaysSara Arena, Alessandra Pattarozzi, Alessandro Corsaro, et al.
Neuro-Degenerative Diseases|June 29, 2007
Amyloid precursor protein and presenilin involvement in cell signalingValentina Venezia, Mario Nizzari, Pia Carlo, et al.
Frontiers in Neuroscience|September 23, 2022
Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targetsStefano Thellung, Alessandro Corsaro, Irene Dellacasagrande, et al.
Omics : a Journal of Integrative Biology|February 11, 2012
Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicityAlessandro Corsaro, Stefano Thellung, Valentina Villa, et al.
Expert Opinion on Therapeutic Targets|November 25, 2024
Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targetsAlessandro Corsaro, Beatrice Tremonti, Adriana Bajetto, et al.
Cancer Cell International|December 24, 2024
The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human glioblastoma cellsAlessandro Corsaro, Irene Dellacasagrande, Michele Tomanelli, et al.
Clinical Endocrinology|October 2, 2002
In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomasMassimo Giusti, Liliana Bocca, Tullio Florio, et al.
Pageof 6